These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 25624196

  • 1. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM, Klein BM, Arce JC.
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [Abstract] [Full Text] [Related]

  • 2. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [Abstract] [Full Text] [Related]

  • 3. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 4. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection.
    Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM.
    Fertil Steril; 2013 Aug; 100(2):430-7. PubMed ID: 23668992
    [Abstract] [Full Text] [Related]

  • 5. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis.
    Broer SL, Dólleman M, van Disseldorp J, Broeze KA, Opmeer BC, Bossuyt PM, Eijkemans MJ, Mol BW, Broekmans FJ, IPD-EXPORT Study Group.
    Fertil Steril; 2013 Aug; 100(2):420-9.e7. PubMed ID: 23721718
    [Abstract] [Full Text] [Related]

  • 6. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O, Eijkemans MJ, Lentjes EW, Torrance HL, Macklon NS, Fauser BC, Broekmans FJ.
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [Abstract] [Full Text] [Related]

  • 7. Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation.
    Baker VL, Gracia C, Glassner MJ, Schnell VL, Doody K, Coddington CC, Shin SS, Marshall LA, Alper MM, Morales AJ, Pavone ME, Behera MA, Zbella EA, Shapiro BS, Straseski JA, Broyles DL.
    Fertil Steril; 2018 Aug; 110(3):506-513.e3. PubMed ID: 29960708
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E, Tolikas A, Daniilidis A, Asimakopoulos B.
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [Abstract] [Full Text] [Related]

  • 9. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
    Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, Oktem M.
    J Assist Reprod Genet; 2013 Jun; 30(5):657-65. PubMed ID: 23508679
    [Abstract] [Full Text] [Related]

  • 10. Antimüllerian hormone as a predictor of good-quality supernumerary blastocyst cryopreservation among women with levels <1 ng/mL versus 1-4 ng/mL.
    Kavoussi SK, Odenwald KC, Boehnlein LM, Summers-Colquitt RB, Pool TB, Swain JE, Jones JM, Lindstrom MJ, Lebovic DI.
    Fertil Steril; 2015 Sep; 104(3):633-6. PubMed ID: 26144573
    [Abstract] [Full Text] [Related]

  • 11. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
    Burks HR, Ross L, Opper N, Paulson E, Stanczyk FZ, Chung K.
    Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
    [Abstract] [Full Text] [Related]

  • 12. Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth.
    Nelson SM, Fleming R, Gaudoin M, Choi B, Santo-Domingo K, Yao M.
    Fertil Steril; 2015 Aug; 104(2):325-32. PubMed ID: 26003269
    [Abstract] [Full Text] [Related]

  • 13. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.
    Anderson RA, Anckaert E, Bosch E, Dewailly D, Dunlop CE, Fehr D, Nardo L, Smitz J, Tremellen K, Denk B, Geistanger A, Hund M.
    Fertil Steril; 2015 Apr; 103(4):1074-1080.e4. PubMed ID: 25681853
    [Abstract] [Full Text] [Related]

  • 14. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT, Linh NK, Tuong HM, Wong PC, Howles CM.
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [Abstract] [Full Text] [Related]

  • 15. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW, Bentzen JG, Thuesen LL, Lauritsen MP, Forman JL, Loft A, Pinborg A, Nyboe Andersen A.
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [Abstract] [Full Text] [Related]

  • 16. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K, Gelbaya TA, Laing I, Nardo LG.
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y, Kim TH, Park JK, Eum JH, Lee HJ, Kim J, Lyu SW, Kim YS, Lee WS, Yoon TK.
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [Abstract] [Full Text] [Related]

  • 18. Comparison of antral follicle count and serum anti Müllerian hormone level for determination of gonadotropin dosing in in-vitro fertilization: randomized trial.
    Li HWR, Ko JKY, Lee VCY, Yung SSF, Lau EYL, Yeung WSB, Ho PC, Ng EHY.
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):303-309. PubMed ID: 31325336
    [Abstract] [Full Text] [Related]

  • 19. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW, Chai J, Li RH, Lee VC, Ho PC, Ng EH.
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [Abstract] [Full Text] [Related]

  • 20. New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count.
    Tadros T, Tarasconi B, Nassar J, Benhaim JL, Taieb J, Fanchin R.
    Fertil Steril; 2016 Dec; 106(7):1800-1806. PubMed ID: 27692436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.